Infectious Disease & Vaccines

ABL specialises in the development and manufacture of advanced biological therapeutics, with a particular focus on gene therapies, vaccines, oncolytics and immunotherapies .…

Acino operates as a speciality pharmaceutical company with a deliberate focus on emerging and underserved markets, channelling its commercial and manufacturing capabilities into…

Rooted in decades of albumin science first pioneered at Delta Biotechnology and later advanced under Novozymes Biopharma, Albumedix is a Nottingham-based biotechnology company…

Dedicated entirely to Phase II-IV clinical trials , Albuquerque Clinical Trials has operated as a locally owned, independent research centre since 1988. Based in Albuquerque, New…

Grounded in a proprietary boron chemistry platform , AN2 Therapeutics is a clinical-stage biopharmaceutical company advancing novel small-molecule therapeutics for rare, chronic,…

Emergex Vaccines is a UK-based clinical-stage biotechnology company developing a new class of synthetic peptide vaccines designed to stimulate cytotoxic T-lymphocyte (CTL)…

Led by Liverpool School of Tropical Medicine and embedded within the North West of England, iiCON (Infection Innovation Consortium) is an open-innovation programme that brings…

Founded by Paul Janssen in Beerse, Belgium in 1953 and now operating as the pharmaceutical division of Johnson & Johnson, Janssen Global stands among the world's foremost…

Founded in 2010 and headquartered in Cambridge, Massachusetts, Moderna is a clinical-stage biotechnology company listed on the Nasdaq (ticker: MRNA) that has built its entire…

Novavax, Inc. is a Gaithersburg, Maryland-based vaccine biotechnology company founded in 1987 and listed on NASDAQ (ticker: NVAX), best known for developing protein subunit…

Founded in 1896 in Basel, Switzerland, Roche has spent more than a century developing medicines and diagnostic tests that together address some of the most complex conditions in…